India’s Compulsory License Debate Set For A Comeback
This article was originally published in PharmAsia News
Executive Summary
The availability of low cost drugs continues to be a top priority for the Indian government. Industry insiders suggest the government is keen to revive the issue of granting compulsory licenses to Indian firms that demonstrate the capability to supply low-priced oncology products.